Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy

NACompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions
Medication Adherence
Interventions
BEHAVIORAL

EMC2

"1. Prescribers will receive a 'Best Practices Alert' which recommends patient counseling on medication use and provides an overview of key medication risks~2. Patients will receive a Medication Guide + Summary with their After Visit Summary~3. Patients will be asked to complete a brief questionnaire on medication use via the patient portal post visit (at both 1 week and 1 month post visit for this phase of the study)~4. Portal assessment results and feedback will be provided to the clinic via an inbox message. Clinic staff will respond to any identified problems according to their own clinical care protocols."

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Northwestern University

OTHER

NCT03652272 - Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy | Biotech Hunter | Biotech Hunter